FDA approves first treatment for Menkes disease in children

The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
Seeking Alpha

argenx Announces U.S. Food and Drug Administration Approval of VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Generalized ...

Amsterdam, the Netherlands—June 20, 2023—argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...
Multiple Sclerosis News Today

FDA approves generic injection to help manage MS

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
Everyday Health on MSN

Should You Switch to the Wegovy Pill?

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...
NBC News

What to watch for in weight loss drugs in 2026

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...
Neurology Advisor

First Treatment for Menkes Disease: FDA Approves Copper Histidinate

The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.